Evidence map›Paper›PMID 31200742›Full record

ArticleMolecular neurodegeneration2019

Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes.

Maria-Adelaide Micci, Balaji Krishnan, Elizabeth Bishop, Wen-Ru Zhang, Jutatip Guptarak, Auston Grant, Olga Zolochevska, Batbayar Tumurbaatar, Whitney Franklin, Claudia Marino and 4 more

Open access · goldAbstract read
In one paragraph

Article in Molecular neurodegeneration, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Restoration of sFRP3 Preserves the Neural Stem Cell Pool and Spatial Discrimination Ability in a Mouse Model of Alzheimer's Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Hippocampal Neural Stem Cell Exosomes Promote Brain Resilience against the Impact of Tau Oligomers.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Maria-Adelaide MicciDepartment of Anesthesiology, University of Texas Medical Branch, Galveston, TX, 77555, USA. mmicci@utmb.edu.
Balaji KrishnanMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Elizabeth BishopDepartment of Anesthesiology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Wen-Ru ZhangMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Jutatip GuptarakDepartment of Anesthesiology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Auston GrantDepartment of Anesthesiology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Olga ZolochevskaMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Batbayar TumurbaatarMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Whitney FranklinMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Claudia MarinoMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Steven G WidenBiochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Arjun LuthraPressent address: The University of Texas at Austin, Austin, TX, 78712, USA.
Steven G KernieDepartment of Pediatrics and Pathology & Cell Biology, Columbia University College of Physicians and Surgeons, New York, NY, 10032, USA.
Giulio TaglialatelaMitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX, 77555, USA. gtaglial@utmb.edu.
The University of Texas Medical Branch at Galveston · USColumbia University · USThe University of Texas at Austin · US

Funding

The Role of ApoE in Injury-Induced NeurogenesisR01NS095803 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KERNIE, STEVEN GERARD · 2017 to 2025
$3.0M
Mechanisms of resistance to cognitive decline in ADR01AG042890 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI TAGLIALATELA, GIULIO · 2013 to 2017
$1.5M
Mechanisms of Resilience to Alzheimer's Disease NeuropathologyR56AG058281 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MICCI, MARIA-ADELAIDE, TAGLIALATELA, GIULIO · 2017 to 2017
$726k
NIA NIH HHS R01 AG042890NIA NIH HHS R56 AG058281
6 · The paper itself

Abstract

backgroundAdult hippocampal neurogenesis plays an important role in synaptic plasticity and cogntive function. We reported that higher numbers of neural stem cells (NSC) in the hippocampus of cognitively-intact individuals with high Alzheimer's disease (AD) pathology (plaques and tangles) is associated with decreased synaptic amyloid beta oligomers (Aβο), an event linked to onset of dementia in AD. While these findings suggest a link between NSC and synaptic resistance to Aβο, the involved mechanism remains to be determined. With this goal in mind, here we investigated the ability of exosomes secreted from hippocampal NSC to promote synaptic resilience to Aβo.

methodsExosomes isolated from media of hippocampus NSC (NSC-exo) or mature hippocampal neuronal (MN-exo) cultures were delivered intracerebroventricularly (ICV) to mice before assessment of Aβο-induced suppression of hippocampal long-term potentiation (LTP) and memory deficits. Aβο binding to synapses was assessed in cultured hippocampal neurons and on synaptosomes isolated from hippocampal slices from wild type mice and from an inducible mouse model of NSC ablation (Nestin-δ-HSV-TK mice) treated with exosomes. Expression of CaMKII and of AMPA and NMDA glutamate receptor subunits in synaptosomes was measured by western blot. Small RNA Deep sequencing was performed to identify microRNAs enriched in NSC-exo as compared to MN-exo. Mimics of select miRNAs were injected ICV.

resultsNSC-exo, but not MN-exo, abolished Aβo-induced suppression of LTP and subsequent memory deficits. Furthermore, in hippocampal slices and cultured neurons, NSC-exo significantly decreased Aβo binding to the synapse. Similarly, transgenic ablation of endogenous NSC increased synaptic Aβo binding, which was reversed by exogenous NSC-exo. Phosphorylation of synaptic CaMKII was increased by NSC-exo, while AMPA and NMDA receptors were not affected. Lastly, we identified a set of miRNAs enriched in NSC-exo that, when injected ICV, protected the synapses from Aβo-binding and Aβo-induced LTP inhibition.

conclusionsThese results identify a novel mechanism linking NSC-exo and synaptic susceptibility to Aβo that may underscore cognitive resilience of certain individuals with increased neurogenesis in spite of AD neuropathology and unmask a novel target for the development of a new treatment concept for AD centered on promoting synaptic resilience to toxic amyloid proteins.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsExosomesHippocampusLong-Term PotentiationMice, Inbred C57BLNeuronal PlasticityRatsSynapsesAmyloid beta-PeptidesAlzheimer’s diseaseAβ oligomersExosomesNeural stem cellsSynapses

Identifiers

PMID31200742
PMCPMC6570890
OpenAlexW2953300673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.